Skip to main content
Skip to main content
THC logo

Tenet Healthcare Corporation (THC) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

$263.46 -$5.62 (-2.09%) |Exceptional · 88
Tenet Healthcare Corporation (THC) bottom line: Bullish Lean — our Council read (68/100) and AI Score (88/100) broadly agree. Strongest signal: Seth Klarman bullish · Biggest watch-out: Ken Griffin bearish.Educational signal, not a buy or sell recommendation. Compare sector peers → · Read the method →
MCap: $21.2B| P/E Ratio: 9.97| Vol: 626K| Target: $284.77 (+8.1%) (Aug 25, 2026) (estimate, not advice)| 52-wk range: $157.58 – $283.05

P/E 9.97 means the share price is 9.97 times one year of earnings per share; the S&P 500 usually sits near 20-25. Market cap $21.2B is the value of all shares combined. Beta 1.50: the stock has moved about 50% more than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Tenet Healthcare Corporation (THC) trades at $263.46 with MoonshotScore 88/100 (Grade A+). Tenet Healthcare Corporation operates a diversified healthcare services business, including hospitals, ambulatory care centers, and healthcare business process services. Market cap: $21.2B, Sector: Healthcare.

Price as of Sep 11, 2026 · Last analyzed: May 10, 2026
Tenet Healthcare Corporation operates a diversified healthcare services business, including hospitals, ambulatory care centers, and healthcare business process services. The company operates 60 hospitals and approximately 550 other healthcare facilities.

THC stock analysis for 2026: Analysts have set a consensus price target of $284.77 for Tenet Healthcare Corporation, suggesting 8.1% upside from the current price of $263.46. The AI MoonshotScore is 88/100, in the Exceptional band (80-100) — a research signal, not a recommendation. Key factors: analyst coverage, AI-driven quantitative scoring.

Watch the THC film Every key number, told as a short cinematic story — just press play. ~2 min

These figures come from statements filed 12 months ago — the most recent this company has published.

Council Score · Weighted Average of 3 Disciplines
Bullish Lean 68/100 · B+

THC: 1/3 scored disciplines lean bullish. Dominant signal: Seth Klarman bullish.

How is this calculated? →
MoonshotScore · Five-pillar engine · 88/100
Business Quality
Strong Is this a genuinely good business?
Financial Safety
Weak Could this blow up on me?
Valuation
Strong Am I paying a fair price?
Growth Durability
Strong Is the growth real and likely to last?
Momentum
Strong Is the market already moving on this?

Strongest side: Business Quality (9/10, Strong). Weakest side: Financial Safety (4/10, Weak).

Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Griffin-style lens (simulated)Ken Griffin
Unfavorable read
Englander-style lens (simulated)Izzy Englander
Neutral read
Klarman-style lens (simulated)Seth Klarman
Favorable read
Moon AI lens (model)
Neutral read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Neutral
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

Why this analysis is different

  • A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Tenet Healthcare Corporation (THC) Healthcare & Pipeline Overview

CEOSaumya Sutaria
Employees88,500
HeadquartersDallas, TX, US
IPO Year1980

Tenet Healthcare Corporation, a diversified healthcare services company, operates hospitals and ambulatory care centers, providing acute care, outpatient services, and healthcare business process solutions. With a $21.2B market cap and a P/E ratio of 9.97, Tenet focuses on expanding its network and optimizing revenue cycle management.

Data Provenance | Financial Data Quantitative Analysis NYSE Analysis: May 10, 2026

What Is the Investment Thesis for THC?

AI-written as of May 10, 2026 — figures and tone reflect the data available then, not today's score.

With a market capitalization of $21.2B and a P/E ratio of 9.97, Tenet demonstrates financial stability and growth potential. The company's focus on expanding its ambulatory care segment and optimizing its healthcare business process services through Conifer are key value drivers. A profit margin of 7.9% and gross margin of 42.8% indicate efficient operations. Upcoming catalysts include further expansion of ambulatory surgery centers and enhanced revenue cycle management solutions. Potential risks include regulatory changes and increasing competition in the healthcare services market. Investors should monitor these factors to assess the long-term viability of Tenet's growth strategy.

Based on FMP financials and quantitative analysis

THC Key Highlights

AI-written as of May 10, 2026 — figures and tone reflect the data available then, not today's score.

Market Cap of $21.2B indicates substantial investor confidence and company size.

  • P/E ratio of 9.97 suggests the company may be undervalued compared to its earnings.
  • Profit Margin of 7.9% demonstrates the company's ability to generate profit from its revenue.
  • Gross Margin of 42.8% reflects efficient cost management in providing healthcare services.
  • Beta of 1.50 indicates the stock is more volatile than the market, potentially offering higher returns but also higher risk.

Who Are THC's Competitors?

THC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
HCA HCA Healthcare, Inc. $426.98 +1.37% $92.4B 815-pillar
EHC Encompass Health Corporation $121.04 -0.40% $12.0B 895-pillar
ENSG The Ensign Group, Inc. $172.79 +0.60% $10.1B 745-pillar
DVA DaVita Inc. $181.33 -0.92% $11.6B 745-pillar
UHS Universal Health Services, Inc. $172.72 -1.74% $10.5B 935-pillar
SOLV Solventum Corporation $87.80 +0.17% $15.2B 595-pillar
FMS Fresenius Medical Care AG & Co. KGaA $22.23 -0.45% $11.9B 825-pillar
CHE Chemed Corporation $514.40 -0.80% $6.72B 865-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are THC's Key Strengths?

Diversified healthcare services offerings.

  • Extensive network of hospitals and ambulatory care centers.
  • Established healthcare business process services segment.
  • Strong relationships with payers and providers.

What Are THC's Weaknesses?

High debt levels.

  • Exposure to regulatory changes and reimbursement pressures.
  • Dependence on government programs (Medicare/Medicaid).
  • Operational challenges in managing a large and complex organization.

What Could Drive THC Stock Higher?

Expansion of ambulatory care network to increase outpatient service capacity.

  • Implementation of value-based care initiatives to improve patient outcomes and reduce costs.
  • Potential acquisitions of smaller healthcare providers to expand geographic reach.
  • Enhancement of healthcare business process services to drive revenue growth.
  • Integration of telemedicine and digital health solutions to improve patient access to care.

What Are the Key Risks for THC?

Insider selling — insiders were net sellers of roughly $46.4M recently.

  • Regulatory changes and reimbursement pressures impacting revenue.
  • Increasing competition in the healthcare services market.
  • Rising operating costs, including labor and supplies.
  • Cyberattacks and data breaches compromising patient data.
  • High debt levels impacting financial flexibility.

What Are the Growth Opportunities for THC?

  • Expansion of Ambulatory Care Services: Tenet has a significant opportunity to grow its ambulatory care segment, including surgical hospitals, ambulatory surgery centers, urgent care and imaging centers. The market for ambulatory surgery centers is projected to reach $47.5 billion by 2027, driven by increasing demand for outpatient procedures and technological advancements. By expanding its network of ambulatory care facilities, Tenet can capture a larger share of this growing market and improve patient access to convenient, cost-effective care. This expansion is expected to contribute significantly to revenue growth over the next 3-5 years.
  • Enhancement of Healthcare Business Process Services: Through its Conifer segment, Tenet offers healthcare business process services, including revenue cycle management, patient communications, and value-based care solutions. The market for healthcare business process outsourcing is expected to reach $111.4 billion by 2028, driven by the need for healthcare providers to improve efficiency and reduce costs. By enhancing its service offerings and expanding its customer base, Tenet can capitalize on this growing market and generate recurring revenue streams. This is an ongoing opportunity with continuous improvements expected.
  • Strategic Acquisitions and Partnerships: Tenet can pursue strategic acquisitions and partnerships to expand its geographic reach and service offerings. The healthcare industry is consolidating, creating opportunities for companies to acquire smaller players and integrate their operations. By acquiring or partnering with complementary businesses, Tenet can strengthen its market position and enhance its competitive advantage. This is an ongoing strategy with potential acquisitions evaluated regularly.
  • Telemedicine and Digital Health Solutions: The increasing adoption of telemedicine and digital health solutions presents a significant growth opportunity for Tenet. The telemedicine market is projected to reach $460 billion by 2030, driven by increasing demand for remote healthcare services and technological advancements. By integrating telemedicine and digital health solutions into its service offerings, Tenet can improve patient access to care, enhance patient engagement, and reduce costs. This is an ongoing opportunity with continuous technology integration.
  • Focus on Value-Based Care: As the healthcare industry shifts towards value-based care models, Tenet has an opportunity to focus on improving patient outcomes and reducing costs. Value-based care models reward healthcare providers for delivering high-quality, cost-effective care. By implementing value-based care initiatives, Tenet can improve its financial performance and enhance its reputation as a leading healthcare provider. This is an ongoing opportunity with continuous quality improvement programs.

What Are THC's Competitive Advantages?

  • Scale and geographic presence: Operates a large network of hospitals and ambulatory care centers.
  • Diversified service offerings: Provides a wide range of healthcare services across multiple segments.
  • Healthcare business process services: Offers specialized services that are difficult to replicate.
  • Established relationships with payers: Has long-standing relationships with insurance companies and government programs.

What Does THC Do?

Tenet Healthcare Corporation, incorporated in 1975 and headquartered in Dallas, Texas, has evolved into a diversified healthcare services provider. The company operates through three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer a wide array of services, including acute care, operating and recovery rooms, radiology and respiratory therapy, clinical laboratories, and pharmacies. They also provide intensive and critical care, coronary care units, and specialized services in cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics. Tenet also delivers outpatient services, such as physical therapy, and advanced procedures like cardiothoracic and complex spinal surgery. The company's ambulatory care segment includes surgery and urgent care centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals. Through Conifer, Tenet offers healthcare business process services, including revenue cycle management, patient communications, and value-based care solutions, serving hospitals, health systems, physician practices, and employers. As of February 2022, Tenet operated 60 hospitals and approximately 550 other healthcare facilities.

What Products and Services Does THC Offer?

  • Operates general hospitals offering acute care services.
  • Provides operating and recovery rooms for surgical procedures.
  • Offers radiology and respiratory therapy services.
  • Manages clinical laboratories and pharmacies within its hospitals.
  • Provides intensive and critical care units for seriously ill patients.
  • Operates ambulatory surgery and urgent care centers.
  • Offers healthcare business process services, including revenue cycle management.
  • Manages patient communications and engagement support.

How Does THC Make Money?

  • Generates revenue from hospital operations, including inpatient and outpatient services.
  • Earns fees from ambulatory care services, such as surgery and urgent care centers.
  • Provides healthcare business process services to hospitals and physician practices.
  • Receives payments from insurance companies, government programs (Medicare/Medicaid), and patients.

What Industry Does THC Operate In?

Tenet Healthcare operates within the medical care facilities industry, which is experiencing growth due to an aging population and increasing demand for healthcare services. The industry is characterized by a mix of large hospital chains and smaller independent facilities. Tenet competes with companies like HCA Healthcare, Inc. and Universal Health Services, Inc., focusing on expanding its ambulatory care services to capture a larger share of the outpatient market. The industry is also facing challenges related to regulatory changes, reimbursement pressures, and rising operating costs.

Who Are THC's Key Customers?

  • Patients seeking acute care and specialized medical services.
  • Hospitals and health systems requiring business process services.
  • Physician practices needing revenue cycle management solutions.
  • Employers seeking value-based care solutions for their employees.
Model self-rating on this text: 73% (not a measure of the evidence) Updated: May 10, 2026

Research confidence

High 100/100

Broad, current evidence sits behind this analysis.

  • Scored on 100% of our measures
  • Price is current
  • Latest filing 44 days ago
  • Covered by analysts

Why 88?

Measured against companies in the same sector. The figures below are the factor contributions the scoring engine itself produced.

What is helping

  • +0.71 Return on equity (Business Quality)
  • +0.54 Financial-health checklist (Financial Strength)
  • +0.31 Free cash flow growth (Growth)

What is holding it back

  • -0.60 Debt to equity (Financial Strength)
  • -0.25 Net debt vs earnings (Financial Strength)
  • -0.16 Earnings growth (Growth)

Contribution = how far the company sits from its sector on that measure, weighted by how much the pillar counts. Not investment advice. How the score is built →

MoonshotScore History

Recorded daily since 2026-08-23 · 19 snapshots

2026-08-23 87
2026-08-26 87
2026-08-29 88
2026-09-01 88
2026-09-04 88
2026-09-07 88
2026-09-10 89

What changed?

The grade moved from 87 to 89 (+2).

What moved it up or down:

  • +3 Momentum
  • +1 Business Quality
  • +1 Growth Durability

Held back by:

  • -1 Valuation

Over the same 18 days the stock moved -4.2%.

Tenet Healthcare Corporation (THC) Valuation Context

Valued at $21.2B, THC is classified as a large-cap stock. Analyst price targets span from $242.00 to $308.00, with a consensus of $284.77. At the current price of $263.46, that implies approximately 8% upside potential. Relative to its peer group, THC's quantitative score of 88/100 is roughly in line with the peer average of 80/100.

THC Revenue & Earnings Trend

In Q2 FY2026, THC generated $5.63B in top-line revenue, marking a sequential increase of 4.8%. The company recorded net income of $826.0M, with diluted EPS of $9.84. Quarter-over-quarter revenue has been mixed, typical for a large-cap company operating in Healthcare. Across the four most recent quarters, THC averaged $6.48 in diluted EPS.

Company Profile

Tenet Healthcare Corporation operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Dallas, US. The company is led by CEO Saumya Sutaria. THC has traded publicly since 1980.

ROE 51%

Key Financial Metrics

Return on equity for Tenet Healthcare Corporation stands at 50.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 7.3%, showing how much profit it generates from its asset base. THC trades at a trailing price-to-earnings ratio of 9.97, below the Healthcare sector average of ~21.50x. Its free cash flow yield is 14.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.41 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 10.0%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 7/9

Financial Health

Tenet Healthcare Corporation's Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 2.10 places it in the grey zone, a middle ground that warrants monitoring.

8/8 beats

Earnings Track Record

Tenet Healthcare Corporation has beaten Wall Street's EPS estimate in 8 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 26.0% above estimates on average.

Net selling

Insider Activity

Over the past six months, Tenet Healthcare Corporation insiders filed 63 SEC Form 4 transactions — 41 sales and 22 purchases. On net that is roughly 164K shares disposed (about $46.4M), a signal worth weighing alongside the fundamentals.

THC Financials

Fundamental Snapshot

Revenue Growth (FY)
+3.1%
Net Income Growth (FY)
-56.0%
EPS Growth (FY)
-52.7%
Free Cash Flow Growth (FY)
+126.7%
P/E (TTM)
9.97
Return on Equity (TTM)
+50.6%
Current Ratio
1.4
EV/EBITDA (TTM)
6.4

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Diversified healthcare services offerings.
  • Extensive network of hospitals and ambulatory care centers.
  • Established healthcare business process services segment.
  • Strong relationships with payers and providers.

Bear Case

  • High debt levels.
  • Exposure to regulatory changes and reimbursement pressures.
  • Dependence on government programs (Medicare/Medicaid).
  • Operational challenges in managing a large and complex organization.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · September 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q2 FY2026 $5.63B $826M $9.84
Q1 FY2026 $5.37B $702M $8.01
Q4 FY2025 $5.53B $371M $4.22
Q3 FY2025 $5.29B $342M $3.86

Q2 FY2026 · filed 29 Jul 2026 · SEC EDGAR →

Based on FMP financials and quantitative analysis

THC Latest News

THC Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for THC.

Price Targets

Low
$242.00
Consensus
$284.77
High
$308.00

Median: $285.00 (+8.1% from current price)

Source: FMP analyst consensus · as of Aug 25, 2026 · an estimate, not advice

THC MoonshotScore

88/100

What does this score mean?

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. THC scores 88/100 (Grade A+): the number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Latest Tenet Healthcare Corporation Analysis

Leadership: Saumya Sutaria

CEO

Saumya Sutaria is the CEO of Tenet Healthcare Corporation, managing a workforce of 98,000 employees. His background includes extensive experience in the healthcare industry. He has held various leadership positions, demonstrating expertise in strategic planning, operational management, and financial performance. Sutaria's career reflects a commitment to innovation and improving healthcare delivery.

Track Record: Under Saumya Sutaria's leadership, Tenet Healthcare has focused on expanding its ambulatory care services and enhancing its healthcare business process solutions. Key achievements include improving operational efficiency and driving revenue growth. Strategic decisions have centered on optimizing the company's portfolio and investing in technology to enhance patient care and streamline operations.

What Investors Ask About Tenet Healthcare Corporation (THC) — Healthcare

What does the AI Score mean for THC?

THC holds an AI Score of 88/100 (Grade: A+). This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. Tenet Healthcare Corporation operates a diversified healthcare services business, including hospitals, ambulatory care centers, and healthcare business process services.

Is THC a good stock?

Stock Expert AI does not rate THC buy, sell or hold. Tenet Healthcare Corporation carries a MoonshotScore of 88/100 on the five-pillar engine, a research rating against its peers. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.

What are the main risks for THC?

Tenet Healthcare Corporation faces several key risks, including regulatory changes impacting reimbursement rates and operational compliance. Increasing competition in the healthcare services market could erode market share and profitability. Rising operating costs, particularly labor and supply expenses, pose a threat to margins.

What are the key factors to evaluate for THC?

Tenet Healthcare Corporation (THC) holds a MoonshotScore of 88/100 (high). P/E: 9.97x vs the S&P 500's ~20-25x. Analysts target $284.77 (+8%). Not financial advice.

How frequently does THC data refresh on this page?

THC's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven THC's recent stock price performance?

Tenet Healthcare Corporation (THC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified healthcare services offerings. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider THC overvalued or undervalued right now?

Tenet Healthcare Corporation (THC) trades at 9.97x earnings. Analysts target $284.77 (+8%) — near fair value. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of THC?

Yes, most major brokerages offer fractional shares of Tenet Healthcare Corporation (THC) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track THC's earnings and financial reports?

Tenet Healthcare Corporation (THC) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for THC earnings announcements.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated MoonshotScore as of
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available data as of 2026-05-10.
  • Financial metrics are based on the most recent available reports.
  • Industry trends and market projections are based on third-party research and analysis.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover